Arjmand Babak, Goodarzi Parisa, Alavi-Moghadam Sepideh, Payab Moloud, Aghayan Hamid Reza, Mohamadi-Jahani Fereshteh, Tayanloo-Beik Akram, Mehrdad Neda, Larijani Bagher
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Methods Mol Biol. 2021;2286:227-235. doi: 10.1007/7651_2020_283.
Schwann cells as glial cells in the peripheral nervous system can participate in neurons protection and forming myelin. Additionally, they are important for nerve pulse conduction supporting along axons. On the other hand, it was demonstrated that they are promising cells for the treatment of demyelinating disorders and also central nervous system damages. Herein, for therapeutic application, Schwann cells should be manufactured based on good manufacturing practice standards to achieve safe and effective clinical products. In this respect, the current chapter tries to introduce a standard protocol for manufacturing of human GMP-compliant Schwann cells for clinical application.
施万细胞作为周围神经系统中的神经胶质细胞,可参与神经元保护和髓鞘形成。此外,它们对于沿轴突的神经脉冲传导支持也很重要。另一方面,已证明它们是治疗脱髓鞘疾病以及中枢神经系统损伤的有前景的细胞。在此,为了治疗应用,应按照良好生产规范标准制造施万细胞,以获得安全有效的临床产品。在这方面,本章试图介绍一种用于制造符合人用药品生产质量管理规范的临床应用施万细胞的标准方案。